AstraZeneca PLC Stock Target Price and Analyst Consensus

AZN Stock  USD 68.73  0.20  0.29%   
The current analyst and expert consensus on AstraZeneca PLC is Strong Buy, with 7 strong buy opinions. The current projected AstraZeneca PLC target price consensus is 83.71 with 13 analyst opinions. The most common way AstraZeneca PLC ADR analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview AstraZeneca PLC executives and customers to further validate their buy or sell advice. AstraZeneca PLC buy-or-sell recommendation module provides average expert sentiment on the projected AstraZeneca PLC ADR target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on AstraZeneca PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
76.18
Highest Forecast
92.92
Target Price
83.71
At this time, AstraZeneca PLC's Pretax Profit Margin is very stable compared to the past year. As of the 16th of April 2024, Operating Profit Margin is likely to grow to 0.22, while Gross Profit is likely to drop about 19.9 B. At this time, AstraZeneca PLC's Non Current Assets Total are very stable compared to the past year. As of the 16th of April 2024, Non Currrent Assets Other is likely to grow to about 1.4 B, while Property Plant And Equipment Net is likely to drop about 6.8 B.
  
It's important to approach AstraZeneca PLC's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize AstraZeneca PLC price targets

AstraZeneca PLC's stock target price is an estimate of its future price, usually made by analysts. Using AstraZeneca PLC's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at AstraZeneca PLC's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if AstraZeneca PLC's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional AstraZeneca PLC Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of AstraZeneca PLC is a key component of AstraZeneca PLC valuation and have some predictive power on the future returns of a AstraZeneca PLC.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AstraZeneca PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
67.5268.7569.98
Details
Intrinsic
Valuation
LowRealHigh
61.8675.2376.47
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.991.321.88
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AstraZeneca PLC. Your research has to be compared to or analyzed against AstraZeneca PLC's peers to derive any actionable benefits. When done correctly, AstraZeneca PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AstraZeneca PLC ADR.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
USD Crypto Fund Idea
USD Crypto Fund
Invested one share
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out Macroaxis Advice on AstraZeneca PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
The data published in AstraZeneca PLC's official financial statements usually reflect AstraZeneca PLC's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AstraZeneca PLC ADR. For example, before you start analyzing numbers published by AstraZeneca accountants, it's critical to develop an understanding of what AstraZeneca PLC's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of AstraZeneca PLC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AstraZeneca PLC's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AstraZeneca PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AstraZeneca PLC ADR. Please utilize our Beneish M Score to check the likelihood of AstraZeneca PLC's management manipulating its earnings.